Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
64.78
-0.55 (-0.84%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gilead Sciences
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs
October 02, 2023
CAR T therapies have major advantages over traditional cancer drugs. Here are three of the best cancer drug stocks set to benefit from CAR T.
Via
InvestorPlace
3 Magnificent Dividend Stocks to Buy in October
September 30, 2023
These stocks come with great dividends and more.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 29, 2023
Via
Benzinga
Two Trial Halts In A Row - Gilead Sciences Stops Late Stage COVID-19 Study
September 28, 2023
Gilead Sciences Inc (NASDAQ: GILD) said it has
Via
Benzinga
Exposures
COVID-19
Gilead Sciences Adapts to Economic Shifts to Support Investor Confidence
September 28, 2023
By the end of today, September 28, 2023, Gilead Sciences (NASDAQ:GILD) is set to deliver a dividend payout of $0.75 per share, equating to an annualized dividend yield of 3.96%.
Via
Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
September 27, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
How Is The Market Feeling About Gilead Sciences?
September 21, 2023
Via
Benzinga
Gilead Sciences Unusual Options Activity
September 20, 2023
Via
Benzinga
$100 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today
September 18, 2023
Via
Benzinga
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
September 21, 2023
Many stocks have nosebleed valuations. But not these.
Via
The Motley Fool
1 Huge Risk That Gene-Editing Stock Investors Desperately Need to Know
September 19, 2023
Good medicines aren't always good business.
Via
The Motley Fool
Time For Gilead Sciences-Heavy ETFs?
September 12, 2023
Gilead Sciences has underperformed the broader market this year by a hefty margin.
Via
Talk Markets
Gilead's Breast Cancer Drug Shows Promise When Combined With Merck's Treatment
September 11, 2023
Gilead Sciences Inc (NASDAQ: GILD) revealed early data from its open-label, Phase 2 EVOKE-02 study evaluating Trodelvy.
Via
Benzinga
What You Need to Know About Hepatitis C This Recovery Month
September 08, 2023
(BPT) - Hepatitis C (HCV) is often referred to as the 'silent disease' due to silent symptoms that may not appear until years after exposure. In fact, of the more than 2 million Americans who are...
Via
Brandpoint
Exposures
COVID-19
How To Earn $500 A Month From Gilead Sciences Stock
September 08, 2023
Shares of Gilead Sciences, Inc (NASDAQ: GILD) are trading higher during Friday’s trading session, bolstered by the Bank of America Securities bullish outlook on the stock.
Via
Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $9,000 Today
September 07, 2023
Via
Benzinga
Where Gilead Sciences Stands With Analysts
September 06, 2023
Via
Benzinga
(GILD) - Analyzing Gilead Sciences's Short Interest
September 05, 2023
Via
Benzinga
Infectious Disease Player Vir Biotech Has Limited Near Term Upside, Analyst Downgrades
September 08, 2023
BofA Securities has downgraded Vir Biotechnology Inc (NASDAQ: VIR) to Neutral from Buy with a price target of $14,
Via
Benzinga
The Unexpected Reason Gilead Just Notched Its Biggest Single-Day Move In A Month
September 08, 2023
Gilead shares are on the rise amid an unexpected boon for its HIV treatment business.
Via
Investor's Business Daily
Gilead Sciences Shares Trade Higher After Bullish Analyst Upgrades Stock
September 08, 2023
Shares of Gilead Sciences, Inc. (NASDAQ: GILD) are trading higher into Friday’s trading session after Bank of America Securities upgraded the stock, highlighting an underappreciated growth potential in...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023
September 08, 2023
Via
Benzinga
Adobe To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Friday
September 08, 2023
B of A Securities cut the price target for DigitalOcean Holdings, Inc. (NYSE: DOCN) from $47 to $25. B of A Securities analyst Wamsi Mohan downgraded the stock from Buy to Underperform. DigitalOcean...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
September 06, 2023
Via
Benzinga
3 No-Brainer Dividend Stocks to Buy in September
September 02, 2023
Income investors should really like these biopharma stocks with juicy dividends.
Via
The Motley Fool
Nearing Retirement? These Stocks Will Pay You For Life
August 29, 2023
These companies are passive income machines.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
August 28, 2023
Via
Benzinga
GILD Stock Alert: FDA Approves Gilead Sciences’ Veklury Covid-19 Treatment
August 24, 2023
Gilead Sciences (GILD) stock is on the move Thursday following additional FDA approval for its Veklury Covid-19 treatment.
Via
InvestorPlace
Exposures
COVID-19
Product Safety
Who Are Other Players Gaining From Roche's Accidental Lung Cancer Data Update
August 23, 2023
Earlier today, Roche Holdings AG (OTC: RHHBY) announced that it had been made aware of inadvertent disclosure of the second interim analysis of Phase 3 SKYSCRAPER-01 study, evaluating tiragolumab plus...
Via
Benzinga
How Roche's Accidental Cancer Update Lifted Iteos And Arcus More Than 30%
August 23, 2023
Roche provided an update from its study in lung cancer using an anti-TIGIT drug.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.